Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

BATS BZX Real-Time Price
As of 12:46pm ET
 -0.84 / -0.75%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.


1 month+6.07% 3 years+2.38%
3 months-0.18% 5 years+18.41%
1 year+20.79% Since inception+7.58%
Data through 01/13/2018

Quote Details

Previous close$111.98
Open day’s range111.11 – 113.30
Net asset value (NAV)112.02 (01/12/2018)
Daily volume139,838
Average volume (3 months)2,644,122
Data as of 12:46pm ET, 01/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.41%+17.28%
Expense Gross exp ratio0.47%1.32%
Risk 5 year sharpe ratio0.861.11
Net assets$9.9B$3.0B
Average market cap$15.7B$9.3B
Average P/E20.221.7
Dividend / Share--0.33%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene8.14%
AMGN Amgen7.79%
BIIB Biogen7.78%
GILD Gilead Sciences7.54%
REGN Regeneron Pharmaceuticals5.29%
VRTX Vertex Pharmaceuticals Inc4.09%
ILMN Illumina Inc3.74%
ALXN Alexion Pharmaceuticals Inc3.66%
MYL Mylan NV3.11%
INCY Incyte Corp2.74%